The activation of the RAS ERK signaling pathway has been implicated in various types of cancer including melanoma, and the suppression of the protein-tyrosine phosphatase SHP-2 encoded by PTPN11 gene favors tumorigenesis due to an alteration of the STAT3 pathway, a pathway involved in the genesis of melanoma. The gene discussed is PTPN11; the disease is cancer.